Muddy Waters Research had a few words regarding St. Jude Medical in a recent report. The short seller made predictions regarding the devicemaker’s revenue and…

BioLineRx has teamed up with I-Bridge Capital to set up a Chinese drug development joint venture, iPharma.

An NIH team has tested a nanovaccine in mice, which has the potential to make cancer immunotherapy more effective while also reducing side effects.

Tel Aviv University researchers have discovered the mechanism by which melanoma metastasizes: The tumor releases vesicles filled with microRNA, a process that…

Contract research and manufacturing firm AMRI ($AMRI) has signed a deal with a pioneer of gene editing, the Broad Institute of MIT and Harvard, to get its…

Just two months after signing a CAR-T deal with Baylor, London-based Cell Medica has penned a new pact with University College London (UCL) to use its T-cell…

Promethera Biosciences is planning to IPO in April or May to raise €40 million for its pipeline of liver cell therapies.

Pfizer, $14 billion down after its biotech bonanza buyout of Medivation in cash this week, still has money in the pot to buy AstraZeneca’s antibiotics unit.